Safety and tolerability of velafermin (CG53135-05) in patients receiving high-dose chemotherapy and autologous peripheral blood stem cell transplant

By Schuster Michael  

Supportive Care in Cancer, Vol. 16, Iss. 5, 2008-05 ,pp. : 477-483

Springer Publishing Company

Access to resources Recommend Favorite

Lymphocyte recovery on day 100 after allogeneic hematopoietic stem cell transplant predicts non-relapse mortality in patients with acute leukemia or myelodysplastic syndrome

By Yamamoto Wataru   Ogusa Eriko   Matsumoto Kenji   Maruta Atsuo   Ishigatsubo Yoshiaki   Kanamori Heiwa  

Leukemia and Lymphoma, Vol. 55, Iss. 5, 2014-05 ,pp. : 1113-1118

Informa Healthcare

Access to resources Recommend Favorite

Multicenter validation of scoring system of pre-transplant serum ferritin and disease risk in patients with acute myeloid leukemia and myelodysplastic syndrome after allogeneic hematopoietic stem cell transplant

By Tachibana Takayoshi  

Leukemia and Lymphoma, Vol. 54, Iss. 6, 2013-06 ,pp. : 1318-1320

Informa Healthcare

Access to resources Recommend Favorite

Retrospective analysis of the efficacy and tolerability of levetiracetam in brain tumor patients

By Newton Herbert   Goldlust Samuel   Pearl Dennis  

Journal of Neuro-Oncology, Vol. 78, Iss. 1, 2006-05 ,pp. : 99-102

Springer Publishing Company

Access to resources Recommend Favorite

Retrospective analysis of the efficacy and tolerability of levetiracetam in patients with metastatic brain tumors

By Newton Herbert   Dalton Jennifer   Goldlust Samuel   Pearl Dennis  

Journal of Neuro-Oncology, Vol. 84, Iss. 3, 2007-09 ,pp. : 293-296

Springer Publishing Company

Access to resources Recommend Favorite